Dexcom (DXCM) Financial Forecast Calculator
Interactive 5-year forecast and DCF for Dexcom. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Dexcom’s most recent SEC filings.
Assumptions
Need this as an Excel model?
Keep iterating on the Dexcom forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.
Other Healthcare forecasts
Run the same calculator on a peer.
Frequently asked
What does Dexcom do and what is its primary business model?+
Dexcom, Inc. develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes, providing real-time glucose readings. Its business model is primarily "razor/razorblade," where durable hardware sales are supplemented by the vast majority of revenue coming from recurring consumable sensor sales.
What are the main drivers of Dexcom's revenue growth?+
Dexcom's revenue growth is driven by increasing CGM market penetration, international expansion into regions like Asia-Pacific, and new product launches such as the Stelo over-the-counter CGM and the G7 15-day sensor. Sensor and other revenue accounts for over 90% of total revenue, indicating the importance of recurring sales.
What is Dexcom's historical capital expenditure as a percentage of revenue?+
Historically, Dexcom's capital expenditure has ranged from 4-7% of revenue, with peaks during significant facility constructions like the Malaysia manufacturing site. Approximately 80% of this capex is allocated to growth initiatives, such as new automated manufacturing lines, rather than just maintenance.
What are the key cost assumptions in a financial model for Dexcom?+
Key cost assumptions include COGS at approximately 34.78% of revenue, R&D at about 17.79% of revenue, and SGA at roughly 33.50% of revenue. These percentages reflect the company's investment in product development and market expansion.
How does Dexcom's working capital profile impact its free cash flow generation?+
Dexcom maintains a positive net working capital, which requires ongoing investment as the company expands globally. Its Days Inventory Outstanding (DIO) is kept high at 90-110 days to ensure global supply chain resilience, influencing its cash conversion cycle.
Can I download an Excel financial model for Dexcom (DXCM) and what is its forecast horizon?+
Yes, an Excel financial model for Dexcom (DXCM) is available for download, providing a comprehensive equity valuation and scenario planning tool. The model offers a forecast horizon from FY2026 through FY2030.
Have more financial modelling questions? Contact us
